We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$22.8B
AUM Growth
+$2.32B
(+11%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-2.13%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
1,019
New
29
Increased
317
Reduced
427
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$47M |
| 2 |
Qiagen
QGEN
|
+$31.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$29.5M |
| 4 |
Amazon
AMZN
|
+$27.9M |
| 5 |
Tesla
TSLA
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
Charter Communications
CHTR
|
+$79.7M |
| 3 |
Comcast
CMCSA
|
+$70.1M |
| 4 |
Stellantis
STLA
|
+$55.4M |
| 5 |
Union Pacific
UNP
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
826
DELISTED
Blueprint Medicines
BPMC
| – | – |
-12,566
| Closed | -$1.22M |
|
827
Brady Corp
BRC
$4.46B
| – | – |
-22,450
| Closed | -$1.2M |
|
828
B2Gold
BTG
$4.98B
| – | – |
-10,615
| Closed | -$46K |
|
829
Blackstone
BX
$104B
| – | – |
-2,860
| Closed | -$213K |
|
830
Blackstone Mortgage Trust
BXMT
$2.77B
| – | – |
-44,665
| Closed | -$1.39M |
|
|
CADE
831
DELISTED
Cadence Bank
CADE
| – | – |
-62,285
| Closed | -$2.02M |
|
832
Cal-Maine
CALM
$4.43B
| – | – |
-29,573
| Closed | -$1.14M |
|
833
CarGurus
CARG
$3.34B
| – | – |
-51,272
| Closed | -$1.22M |
|
834
CEVA Inc
CEVA
$831M
| – | – |
-22,297
| Closed | -$1.25M |
|
835
Chemed
CHE
$7.16B
| – | – |
-2,581
| Closed | -$1.19M |
|
836
Cirrus Logic
CRUS
$6.76B
| – | – |
-15,407
| Closed | -$1.31M |
|
837
CorVel
CRVL
$3.18B
| – | – |
-34,743
| Closed | -$1.19M |
|
838
Castle Biosciences
CSTL
$742M
| – | – |
-19,319
| Closed | -$1.32M |
|
|
CSW
839
CSW Industrials
CSW
$4.44B
| – | – |
-9,049
| Closed | -$1.22M |
|
840
Commault Systems
CVLT
$4.98B
| – | – |
-18,965
| Closed | -$1.22M |
|
841
Casella Waste Systems
CWST
$5.76B
| – | – |
-18,601
| Closed | -$1.18M |
|
842
Darling Ingredients
DAR
$9.32B
| – | – |
-15,795
| Closed | -$1.16M |
|
843
Donaldson
DCI
$10.7B
| – | – |
-20,705
| Closed | -$1.2M |
|
844
Deckers Outdoor
DECK
$14.1B
| – | – |
-22,890
| Closed | -$1.26M |
|
845
Dolby
DLB
$4.97B
| – | – |
-12,383
| Closed | -$1.22M |
|
846
Dorman Products
DORM
$4.22B
| – | – |
-11,732
| Closed | -$1.2M |
|
847
Enanta Pharmaceuticals
ENTA
$362M
| – | – |
-24,885
| Closed | -$1.23M |
|
848
Entegris
ENTG
$16.3B
| – | – |
-11,594
| Closed | -$1.3M |
|
849
Energy Recovery
ERII
$420M
| – | – |
-67,271
| Closed | -$1.23M |
|
850
ESCO Technologies
ESE
$7.77B
| – | – |
-24,287
| Closed | -$2.65M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2021 Portfolio in Review
As of Q2 2021, Aviva held 1,019 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q2 2021 filing shows 29 new, 317 increased, 427 reduced and 158 closed positions. Its largest new stake was DoorDash: 44,570 shares worth $7.95M. The largest sale was Alibaba, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2021 buy was DoorDash: 44,570 shares worth $7.95M.
- Aviva added most to Meta Platforms (Facebook) in Q2 2021, an estimated $47M increase.
- Aviva's biggest Q2 2021 reduction was Alibaba, cutting an estimated $138M.
- Aviva fully exited Kilroy Realty in Q2 2021, selling an estimated $8.36M.
- Aviva's ten largest holdings make up 23% of its $22.8B portfolio in Q2 2021.
- Aviva opened 29 new positions and closed 158 in Q2 2021.
- Aviva's portfolio value rose 11% quarter-over-quarter to $22.8B.
Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.